Related Experiment Video

Updated: Mar 6, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.3K

Regulation of MUC5B Expression in Idiopathic Pulmonary Fibrosis

Britney A Helling1, Anthony N Gerber1,2, Vineela Kadiyala2

  • 11 Department of Medicine, School of Medicine, University of Colorado-Denver, Denver, Colorado.

American Journal of Respiratory Cell and Molecular Biology
|March 9, 2017
PubMed

Insights

A common genetic variant increases idiopathic pulmonary fibrosis risk by altering MUC5B gene expression. Researchers found a regulatory region involving FOXA2 protein binding and methylation, offering new therapeutic targets.

Area of Science:

  • Pulmonary Medicine
  • Genetics
  • Molecular Biology

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with limited treatment options.
  • A specific MUC5B promoter variant (rs35705950) is the largest known genetic risk factor for IPF.
  • The molecular mechanisms driving MUC5B overexpression in IPF remain unclear.

Purpose of the Study:

  • To elucidate the regulatory mechanisms of MUC5B expression, particularly in relation to the rs35705950 variant.
  • To identify key proteins and epigenetic modifications involved in MUC5B gene regulation.

Main Methods:

  • Analysis of a critical regulatory domain containing the MUC5B promoter variant.
  • Investigation of DNA methylation patterns in relation to IPF, MUC5B expression, and the variant.
  • Chromatin immunoprecipitation assays to assess forkhead box protein A2 (FOXA2) binding dynamics.
  • Functional studies to determine FOXA2's role in MUC5B expression.

Main Results:

  • A conserved FOXA2 binding motif was identified within the critical regulatory domain.
  • Differential DNA methylation was observed in this region, correlating with IPF, MUC5B levels, and the rs35705950 variant.
  • FOXA2 dynamically binds to this locus, and its binding is essential for increased MUC5B expression.

Conclusions:

  • The study identifies a novel regulatory mechanism for MUC5B expression involving FOXA2 and DNA methylation.
  • These findings highlight a critical genetic and epigenetic interplay in IPF pathogenesis.
  • The identified regulatory elements and protein interactions present potential therapeutic targets for IPF.
Keywords:
DNA methylationgene regulationidiopathic pulmonary fibrosismucin 5Bmucins

More Related Videos

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins09:24

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

Published on: June 14, 2016

27.3K
Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer08:47

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on: April 21, 2022

4.0K

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
966
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
593
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K